Review · Current issues in molecular biology · 2025Conflicts declared

Quinoa compounds and colon health, from lab to small human studies

What it found

Quinoa and its compounds may help gut bacteria, calm inflammation and support the colon, but most evidence comes from cells and animals.

One small study in 19 people with celiac disease found quinoa was well tolerated and improved gut measurements.

What they found

Studies in people

Celiac disease in people

In 19 celiac patients eating 50 g quinoa daily for six weeks, gut measurements improved, including villus height-to-crypt depth ratio returning to normal. The diet was well tolerated and did not worsen the disease.

Animal and lab studies

Inflammation in animals

In mice with colitis, quinoa polysaccharides reduced colon shortening and increased short-chain fatty acid production. Quinoa saponins also improved gut bacteria balance in mice and lowered inflammatory cytokines.

Colorectal cancer in lab tests

Quinoa fatty acids, saponins, triterpenes and polysaccharides showed anticancer effects in cancer cell studies. They inhibited cell growth, induced cell death and increased sensitivity to chemotherapy in resistant cells.

Quinoa varieties and celiac safety

Lab tests found that 9 of 12 quinoa varieties had low binding to antibodies from celiac patients, suggesting they are suitable. Three varieties showed mild immune reactivity and are considered less suitable for people with celiac disease.

Studies in people and animals

Gut bacteria and polysaccharides

In lab fermentation models, quinoa polysaccharides promoted beneficial bacteria like Bifidobacterium and suppressed Escherichia coli. Animal studies found they shifted gut bacteria toward short-chain fatty acid producers and reduced inflammation.

Other findings

Phytosterols and cholesterol

Quinoa seeds contain up to 118 mg of phytosterols per 100 g, mainly beta-sitosterol. These compounds are known from other studies to lower cholesterol by competing with cholesterol absorption.

What the authors conclude

  • They say quinoa shows promise as a functional food for colon health, with polysaccharides, saponins, phytosterols, fatty acids and triterpenes acting through different pathways.
  • They call for more rigorously designed human clinical research to confirm the benefits seen in animals and lab studies.
  • They advise using precision nutrition and multi-omics approaches to identify who might benefit most from quinoa.

How it was done

Colonic diseases like inflammatory bowel disease and colorectal cancer are rising worldwide, and diet is seen as a way to help manage colon health. The authors wanted to pull together what is known about quinoa's bioactive compounds and their effects on the colon.

They reviewed studies on quinoa polysaccharides, saponins, phytosterols, fatty acids and triterpenes, including lab tests, animal models and a small clinical study. The clinical study involved 19 celiac patients who ate 50 g of quinoa daily for six weeks.

What it can’t tell you

  • Most studies were done in cells or animals, so the results may not apply to people.
  • The human study was very small, with only 19 celiac patients, so its findings cannot be generalised to everyone.
  • The review cannot show that quinoa prevents or treats colon diseases in people.

The paper

Title
Quinoa and Colonic Health: A Review of Bioactive Components and Mechanistic Insights
Type
ReviewThe authors read earlier studies and describe what they found. It isn’t a new study.
Evidence
Studies in people · animals · lab
Summarised from
Full text
Cite
Pan Y, Zheng J, Wang Z, et al (2025). Quinoa and Colonic Health: A Review of Bioactive Components and Mechanistic Insights. Current issues in molecular biology. doi:10.3390/cimb47100815Free full textPubMed 41150762DOI

Summary written 26 Sep 2026. Check it against the paper before it changes what you eat. How we summarise papers · Report an error